[Pathology of the cervix uteri as a consequence of hormonal therapy]
Other
OA: closed
CC0
AI-generated summary
This paper outlines the morphological and functional characteristics of iatrogenic endocervical hyperplasia resulting from prolonged progestin-estrogenic hormonal therapy used to treat endometrial hyperplasia, external and internal endometriosis, and uterine myoma.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Morphological and functional characteristics are outlined for various types of endocervical hyperplasia attributed to prolonged administration of combined hormonotherapy with progestin-estrogenic and gestagen preparations for endometrial hyperplasia, external and internal endometriosis and myoma uteri. Endocervical hyperplasia belongs to iatrogenic pathology. Terminological issues of hyperplasia and differential diagnosis of atypical microglandular hyperplasia and adenocarcinoma are discussed.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-24T06:12:55.650802+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:31:21.846955+00:00
License: CC0
· commercial use OK